Aurobindo Pharma | ARBP - Gross Profit On Sales

Stock Price
1,191.15
Daily Change
8.65 0.73%
Monthly
-3.57%
Yearly
-0.05%
Q1 Forecast
1,189.51

Aurobindo Pharma reported INR49.47B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Cipla INR 41.64B 6.31B Dec/2025
Divis Laboratories Ltd INR 14.54B 1.5B Jun/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Hindustan Unilever INR 79.9B 780M Sep/2025
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
UPL INR 55.96B 1.01B Dec/2025